These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10941245)

  • 1. [Oncology caught between economics and efficiency].
    Keil TU
    Med Klin (Munich); 2000 Jun; 95 Suppl 1():1. PubMed ID: 10941245
    [No Abstract]   [Full Text] [Related]  

  • 2. A time of change in medical oncology. Problems created by the lack of coherence in Australia's health care system.
    Lowenthal RM
    Med J Aust; 1992 Jul; 157(1):28-30. PubMed ID: 1640887
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ethics and economics in oncology].
    Winkler E; Schildmann J
    Onkologie; 2011; 34 Suppl 1():1. PubMed ID: 21389760
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of cancer therapy from the perspective of a statutory health insurance].
    Rebscher H; Schellhammer S; Kopp T; Scharnetzky E
    Urologe A; 2011 Dec; 50(12):1584-90. PubMed ID: 22159704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cancer and health economics].
    Koinuma N
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):1-7. PubMed ID: 8546457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The war on cancer: progress at what price?
    Konski A
    J Clin Oncol; 2011 Apr; 29(12):1503-4. PubMed ID: 21402613
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer care, money, and the value of life: whose justice? Which rationality?
    Sulmasy DP
    J Clin Oncol; 2007 Jan; 25(2):217-22. PubMed ID: 17210943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Benefit-risk evaluation of new drugs as a basis for decisions on prioritization in hematology/oncology: methodical challenges and problem-solving strategies].
    Ludwig WD; Schildmann J
    Onkologie; 2011; 34 Suppl 1():6-10. PubMed ID: 21389762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost of cancer care: issues and implications.
    Meropol NJ; Schulman KA
    J Clin Oncol; 2007 Jan; 25(2):180-6. PubMed ID: 17210937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Economic evaluation in oncology].
    Schöffski O
    Med Klin (Munich); 2000 Jun; 95 Suppl 1():14-7. PubMed ID: 10941248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating economic analysis into cancer clinical trials: the National Cancer Institute-American Society of Clinical Oncology Economics Workbook.
    J Natl Cancer Inst Monogr; 1998; (24):1-28. PubMed ID: 9704318
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rationalization, rationing, prioritization: terminology and ethical approaches to the allocation of limited resources in hematology/oncology].
    Winkler E
    Onkologie; 2011; 34 Suppl 1():2-5. PubMed ID: 21389761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncological resource allocation in Germany.
    Hartmann M; Kath R; Gundermann C
    Onkologie; 2008 Mar; 31(3):85-9. PubMed ID: 18322410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis for clinical procedures in oncology.
    Weinstein MC
    Bull Cancer; 1980; 67(5):491-500. PubMed ID: 6783150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness research in oncology: the need for clarity, transparency and vision.
    Lyman GH
    Cancer Invest; 2009 Jul; 27(6):593-7. PubMed ID: 19557579
    [No Abstract]   [Full Text] [Related]  

  • 16. [Is a jolt passing through oncology?].
    Aumiller J
    MMW Fortschr Med; 2006 May; 148(21):13-4. PubMed ID: 16796182
    [No Abstract]   [Full Text] [Related]  

  • 17. How should we pay the piper when he's calling the tune? On the long-term affordability of cancer care in the United States.
    Ramsey SD
    J Clin Oncol; 2007 Jan; 25(2):175-9. PubMed ID: 17210936
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacoeconomics in uro-oncology: the concept of QALYs].
    Poulsen Nautrup B
    Urologe A; 2011 Dec; 50(12):1573-7. PubMed ID: 22159702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent advances in haematology and oncology].
    Jäger U; Hiddemann W
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2077. PubMed ID: 18985558
    [No Abstract]   [Full Text] [Related]  

  • 20. Affordable oncologic care: a challenging goal.
    Barton MK
    CA Cancer J Clin; 2014; 64(2):75-8. PubMed ID: 24420975
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.